For the active substances cyprodinil, formetanate, halosulfuron-methyl, pirimicarb, triticonazole and ziram, additional information for the purposes of assessment of the approval criteria set out in points 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009 as amended by Regulation (EU) 2018/605, was requested by the Authority pursuant Article 13(3a) of Implementing Regulation (EU) No 844/2012 and was submitted by the applicants within the deadline given. However, additional time is needed for the evaluation of the Authority and for the issuance of the related conclusion by risk assessors, as well as for the Commission to adopt the ensuing risk management decisions.
Recital 30, Regulation (EU) 2025/99
In forcesince 21 Jan 2025